Scilex Holding (SCLXW) Assets Average (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Assets Average of $329.3 million in Q1 2026, up 2.77% quarter-over-quarter from $320.4 million in Q4 2025, and up 283.07% on a YoY basis from $86.0 million in Q1 2025.

Scilex Holding (SCLXW) Assets Average (2021 - 2026) Analysis & Trends

Scilex Holding's Assets Average history runs 6 years deep, the most recent figure standing at $329.3 million for Q1 2026.

  • In Q1 2026, Assets Average rose 283.07% year-over-year to $329.3 million; the TTM figure through Mar 2026 stood at $329.3 million (up 283.07% YoY), while the FY2025 annual figure was $229.0 million, up 135.73% from the prior year.
  • Assets Average was $329.3 million for Q1 2026 at Scilex Holding, up from $320.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $329.3 million in Q1 2026 to a low of $81.4 million in Q2 2025.
  • Historically, Assets Average has averaged $132.0 million across 5 years, with a median of $102.5 million in 2024.
  • The sharpest annual moves came in 2023 and 2026: Assets Average fell 24.98% in 2023, then jumped 283.07% in 2026.
  • A 5-year view of Assets Average shows it stood at $94.0 million in 2022, then fell by 3.27% to $90.9 million in 2023, then increased by 6.35% to $96.7 million in 2024, then surged by 231.39% to $320.4 million in 2025, then grew by 2.77% to $329.3 million in 2026.
  • The last three Assets Average figures came in at $329.3 million (Q1 2026), $320.4 million (Q4 2025), and $179.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 83.03 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 114.53 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 200.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 135.21 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 132.78 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 57.65 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 208.08 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 88.26 Bn
10 Scilex Holding - - 4.15 Mn 329.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 329.31 Mn
Dec 31, 2025 320.43 Mn
Sep 30, 2025 179.82 Mn
Jun 30, 2025 81.37 Mn
Mar 31, 2025 85.96 Mn
Dec 31, 2024 96.69 Mn
Sep 30, 2024 102.49 Mn
Jun 30, 2024 97.89 Mn
Mar 31, 2024 96.27 Mn
Dec 31, 2023 90.92 Mn
Sep 30, 2023 103.50 Mn
Jun 30, 2023 106.26 Mn
Mar 31, 2023 86.29 Mn
Dec 31, 2022 93.99 Mn
Sep 30, 2022 121.88 Mn
Jun 30, 2022 141.64 Mn
Mar 31, 2022 109.45 Mn
Dec 31, 2021 108.79 Mn
Sep 30, 2021 139.77 Mn
Jun 30, 2021 139.98 Mn